Response to Comment on “An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia”

Marjanne A. Piena (), Natalie Houwing (), Carla W. Kraan (), Xiaofeng Wang (), Heidi Waters () and Craig Bennison ()
Additional contact information
Marjanne A. Piena: OPEN Health
Natalie Houwing: OPEN Health
Carla W. Kraan: OPEN Health
Xiaofeng Wang: Otsuka Pharmaceutical Companies
Heidi Waters: Otsuka Pharmaceutical Companies
Craig Bennison: OPEN Health

PharmacoEconomics, 2022, vol. 40, issue 12, No 10, 1265-1267

Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40273-022-01213-y Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:40:y:2022:i:12:d:10.1007_s40273-022-01213-y

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-022-01213-y

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().